Haleon PLC - Surrey, England-based consumer healthcare company, with brands including Sensodyne and Panadol - Commences the up to GBP500 million share buyback programme announced in its 2025 preliminary results on February 25. HSBC Bank PLC has agreed to purchase the shares on its behalf. Haleon says the buyback commences immediately and will end no later than August 19, with all repurchased shares being cancelled.
Current stock price: 369.80 pence, up 1.0% on Thursday in London
12-month change: down 5.1%
By Emma Curzon, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2026 Alliance News Ltd. All Rights Reserved.
Market Reports Corporate News Pharmaceuticals Health Care

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday and not separately reported by Allian...


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...


(Alliance News) - Canal+ SA on Wednesday listed on the Johannesburg Stock Exchange, becoming the first ever French company to list on the bourse.


(Alliance News) - The following London-listed shares received analyst recommendations on Tuesday morning and on Monday:


(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday:


(Alliance News) - Stock prices in London extended losses by midday Wednesday, as weakness among blue chips outweighed strength in smaller caps.


* Haleon warns of rising freight costs


(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Wednesday.


(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.


(Alliance News) - Haleon PLC on Wednesday reported increased quarterly revenue and reiterated its growth forecasts for the year.